6848 Share Price Performance
Recent 6848 News & Updates
No updates
RBC Bioscience Corporation Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.66
- Gross Margin
- 47.78%
- Net Profit Margin
- 10.51%
- Debt/Equity Ratio
- 181.6%
RBC Bioscience Corporation Competitors
About 6848
- Founded
- 1995
- Employees
- 52
- CEO
- WebsiteView website
RBC Bioscience Corporation researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia. It offers molecular biomedical diagnostic and research reagents, gene extraction automatic testing instruments, and gene extraction reagent tissues; automated nucleic acid extractors; and nucleic acid extraction kits. The company sells its products through distributors. RBC Bioscience Corporation was founded in 1995 and is based in New Taipei City, Taiwan.
Taiwanese Market Performance
- 7 Days: 0.6%
- 3 Months: 12.7%
- 1 Year: 2.4%
- Year to Date: 2.3%
Over the last 7 days, the market has remained flat, although notably the Energy sector gained 9.2% in that time. Similarly, the market is flat for the past 12 months. As for the next few years, earnings are expected to grow by 13% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading